CompoAtlas

Dry Eye Omega Benefits Plus

Natural health product licensed in Canada

Other names
Dry Eye Omega Benefits
Licence holder
PRN Canada - Physician Recommended Nutriceuticals Ltd.
NPN or DIN-HM
80029632
Status
Active licence
Licence date
15 February 2012
Revision date
3 January 2018
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vitamine D

Source : Cholécalciférol

Potency : 250 UI

6.25 mcg25 µg
Huile de poisson

Source : Huile du corps de Sardine

Potency : 140 mg DHA (docosahexaenoic acid)

Not specifiedNot calculated
Huile de poisson

Source : Huile du corps de Maquereau

Potency : 140 mg DHA (docosahexaenoic acid)

Not specifiedNot calculated
Huile de poisson

Source : Huile du corps d'Anchois

Potency : 140 mg DHA (docosahexaenoic acid)

Not specifiedNot calculated
Huile de poisson

Source : Triglycerides

Potency : 140 mg DHA (docosahexaenoic acid)

Not specifiedNot calculated
Huile de poisson

Source : Huile du corps de Sardine

Potency : 167 mg Other omega 3 fatty acids

Not specifiedNot calculated
Huile de poisson

Source : Huile du corps de Maquereau

Potency : 167 mg Other omega 3 fatty acids

Not specifiedNot calculated
Huile de poisson

Source : Huile du corps d'Anchois

Potency : 167 mg Other omega 3 fatty acids

Not specifiedNot calculated
Huile de poisson

Source : Triglycerides

Potency : 167 mg Other omega 3 fatty acids

Not specifiedNot calculated

Non-medicinal ingredients

orange naturelle, Gélatine, Natural Berry Flavour

PopulationAgeQuantity per servingFrequency
AdultesNot specified2 Capsule2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps support cognitive health and/or brain function. Source of omega-3 fatty acids for the maintenance of good health. Helps to improve MMP-9, an inflammatory marker in tear film associated with signs and symptoms of dry eyes associated with Meibomian gland dysfunction. Helps to improve signs and relieve symptoms of dry eyes associated with Meibomian gland dysfunction as shown by improved symptom scores based on the Ocular. Surface Disease Index (OSDI). Helps to improve signs and relieve symptoms of dry eyes associated with Meibomian gland dysfunction, such as tear osmolarity and tear break-up time (TBUT).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80029632

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2018. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line